BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21954843)

  • 1. PPAR-γ activator pioglitazone prevents age-related atrial fibrillation susceptibility by improving antioxidant capacity and reducing apoptosis in a rat model.
    Xu D; Murakoshi N; Igarashi M; Hirayama A; Ito Y; Seo Y; Tada H; Aonuma K
    J Cardiovasc Electrophysiol; 2012 Feb; 23(2):209-17. PubMed ID: 21954843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z; Ye P; Long C; Chen K; Li X; Wang H
    Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
    Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
    J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
    Shen X; Li H; Li W; Wu X; Ding X
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits.
    Liu C; Liu R; Fu H; Li J; Wang X; Cheng L; Korantzopoulos P; Tse G; Li G; Liu T
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related increase in atrial fibrillation induced by transvenous catheter-based atrial burst pacing: an in vivo rat model of inducible atrial fibrillation.
    Xu D; Murakoshi N; Tada H; Igarashi M; Sekiguchi Y; Aonuma K
    J Cardiovasc Electrophysiol; 2010 Jan; 21(1):88-93. PubMed ID: 19817931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
    Kalonia H; Kumar P; Kumar A
    Pharmacol Biochem Behav; 2010 Aug; 96(2):115-24. PubMed ID: 20450929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance.
    Hasegawa H; Takano H; Zou Y; Qin Y; Hizukuri K; Odaka K; Toyozaki T; Komuro I
    J Mol Cell Cardiol; 2005 Feb; 38(2):257-65. PubMed ID: 15698832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel strategy to prevent atrial fibrosis and fibrillation.
    Takahashi N; Kume O; Wakisaka O; Fukunaga N; Teshima Y; Hara M; Saikawa T
    Circ J; 2012; 76(10):2318-26. PubMed ID: 22972366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
    Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
    Lahiri S; Sen T; Palit G
    Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure.
    Shimano M; Tsuji Y; Inden Y; Kitamura K; Uchikawa T; Harata S; Nattel S; Murohara T
    Heart Rhythm; 2008 Mar; 5(3):451-9. PubMed ID: 18313605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
    Ye Y; Hu Z; Lin Y; Zhang C; Perez-Polo JR
    Cardiovasc Res; 2010 Aug; 87(3):535-44. PubMed ID: 20164119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A; Wu L; Wang R; de Champlain J
    Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
    Liu T; Zhao H; Li J; Korantzopoulos P; Li G
    Cardiovasc Ther; 2014 Aug; 32(4):178-83. PubMed ID: 24814361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats.
    Reel B; Guzeloglu M; Bagriyanik A; Atmaca S; Aykut K; Albayrak G; Hazan E
    J Surg Res; 2013 Jun; 182(1):176-84. PubMed ID: 22981741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.
    Yamagishi S; Ogasawara S; Mizukami H; Yajima N; Wada R; Sugawara A; Yagihashi S
    J Neurochem; 2008 Jan; 104(2):491-9. PubMed ID: 17995925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone, a PPAR-gamma ligand inhibited the nicotinamide-streptozotocin induced sperm abnormalities in type-2 diabetic Wistar rats.
    Rabbani SI; Devi K; Khanam S
    Pak J Pharm Sci; 2010 Jul; 23(3):326-31. PubMed ID: 20566448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.